Rely on

Radyus.

An R&D operating partner for VC/PE-backed biotech companies.

An R&D operating partner for VC/PE-backed biotech companies.

We are a fully integrated PMO: Program Management Organization. We plan, execute and own drug development end-to-end, from preclinical through clinical proof of concept, so teams move faster and increase their probability of success.

Start a conversation

Our mission is

simple.

Increase the probability of clinical and business success for our clients' drug programs.

Our experienced team of former pharma, biotech, and investor leaders runs R&D programs with milestone-driven discipline. We align regulatory and manufacturing strategy with preclinical and clinical execution into a fully integrated operating model, enabling our clients to deliver on commitments to investors, regulators, and ultimately patients.

The Radyus

Model.

Fully Integrated. PMO-Led Execution. Built for Capital Efficiency.

We replace fragmented vendor stacks with a single, accountable operating layer that integrates strategy, regulatory, CMC, nonclinical, clinical and program management into one execution engine.

We replace fragmented vendor stacks with a single, accountable operating layer that integrates strategy, regulatory, CMC, nonclinical, clinical and program management into one execution engine.

We replace fragmented vendor stacks with a single, accountable operating layer that integrates strategy, regulatory, CMC, nonclinical, clinical and program management into one execution engine.

Poster

Built for

long-term

value.

Full R&D
Integration
Full R&D Integration

Strategy through execution under a single operating model, aligning regulatory, CMC, nonclinical, and clinical into one coordinated framework.

Capital Efficiency by Design

Programs, budgets, and timelines engineered to maximize ROI, reducing waste, accelerating decision-making, and mitigating execution risk.

Expertise Across Key Disease Areas

Deep experience across oncology, immunology, CNS, and metabolic diseases, shaped by pharma, biotech, and venture capital.

Flexible, Agile Partnership Model

A long-term operating partner that adapts to evolving programs, investor priorities, and portfolio strategies.

When development decisions

When development decisions matter,

matter,

rely on Radyus.

Learn how we partner

Our Ideal Clients

We partner with biotech teams

executing complex R&D

under high investor and regulatory expectations.

PE-Backed Platforms

Portfolio-level discipline through a scalable R&D operating model and centralized PMO.

PE-Backed Platforms

Portfolio-level discipline through a scalable R&D operating model and centralized PMO.

Venture Studios

Rapid development readiness with turnkey strategy, R&D setup and efficient execution.

Venture Studios

Rapid development readiness with turnkey strategy, R&D setup and efficient execution.

VC-Backed Biotech

Speed, credibility and capital efficiency, delivered by one accountable, expert R&D team.

VC-Backed Biotech

Speed, credibility and capital efficiency, delivered by one accountable, expert R&D team.

One operating partner.

A global

execution network.

Radyus sits at the center of a curated network of CROs, CDMOs, and specialist partners, giving you global reach without building internal infrastructure.

Korean-based CRO specializing in non-clinical and clinical studies across therapeutic areas known for operational scale and execution quality.

Learn More

Integrated manufacturing partner providing high-quality CMC development and GMP production capabilities across early and mid-stage programs.

Preclinical CRO partner supporting nonclinical development, complex assay systems and specialized scientific platforms.

Korean-based CRO specializing in non-clinical and clinical studies across therapeutic areas known for operational scale and execution quality.

Learn More

Integrated manufacturing partner providing high-quality CMC development and GMP production capabilities across early and mid-stage programs.

Preclinical CRO partner supporting nonclinical development, complex assay systems and specialized scientific platforms.

Our People

Deep operational

experience.

Institutional

know-how.

One

accountable team.

Radyus is led by senior operators with decades of drug development, regulatory, and portfolio strategy experience. Our leadership works hand-in-hand with advisors and scientific thought leaders who have shaped the future of R&D across industry and academia.

Marta New, PhD, MBA

Chief Executive Officer

Marta New, PhD, MBA

Chief Executive Officer

Marta New, PhD, MBA

Chief Executive Officer

Kelly R. Pitts, PhD

President and Chief Operating Officer

Kelly R. Pitts, PhD

President and Chief Operating Officer

Kelly R. Pitts, PhD

President and Chief Operating Officer

Eric Springman, PhD

Head of Development

Eric Springman, PhD

Head of Development

Eric Springman, PhD

Head of Development

David Ford, PhD, PMP

Senior Director of Project Management

David Ford, PhD, PMP

Senior Director of Project Management

David Ford, PhD, PMP

Senior Director of Project Management

Charlotte Chadwick

Head of Clinical Operations

Charlotte Chadwick

Head of Clinical Operations

Charlotte Chadwick

Head of Clinical Operations

Anthony Chilton, PhD

Head of Scientific Operations

Anthony Chilton, PhD

Head of Scientific Operations

Anthony Chilton, PhD

Head of Scientific Operations

Kurt Roinstead, PhD

Manufacturing Lead

Kurt Roinstead, PhD

Manufacturing Lead

Kurt Roinstead, PhD

Manufacturing Lead

David Edwards

Toxicology Lead

David Edwards

Toxicology Lead

David Edwards

Toxicology Lead

Alan Benjamin Frey, PhD

Scientific Development

Alan Benjamin Frey, PhD

Scientific Development

Alan Benjamin Frey, PhD

Scientific Development

Ken McCullough, PhD

Associate Director of Project Management

Ken McCullough, PhD

Associate Director of Project Management

Ken McCullough, PhD

Associate Director of Project Management

Lucy Outtrim

Project Manager

Lucy Outtrim

Project Manager

Lucy Outtrim

Project Manager

Lou Sims

Controller

Lou Sims

Controller

Lou Sims

Controller

Paul Tebbey, PhD, MBA

Co‑founder and Director

Paul Tebbey, PhD, MBA

Co‑founder and Director

Paul Tebbey, PhD, MBA

Co‑founder and Director

Jane McCracken

CRO Operations

Jane McCracken

CRO Operations

Jane McCracken

CRO Operations

Anna Walz

BD Strategy

Anna Walz

BD Strategy

Anna Walz

BD Strategy

Dennis Liotta, PhD

Anti-Infectives

Dennis Liotta, PhD

Anti-Infectives

Dennis Liotta, PhD

Anti-Infectives

Mark Jay Shlomchik, MD, PhD

Immunology

Mark Jay Shlomchik, MD, PhD

Immunology

Mark Jay Shlomchik, MD, PhD

Immunology

Laura Soucek, PhD

Oncology

Laura Soucek, PhD

Oncology

Laura Soucek, PhD

Oncology

Richard B. Silverman, PhD

CNS / Neuro

Richard B. Silverman, PhD

CNS / Neuro

Richard B. Silverman, PhD

CNS / Neuro

Frederick (Rick) Sax, MD

Cardiometabolic

Frederick (Rick) Sax, MD

Cardiometabolic

Frederick (Rick) Sax, MD

Cardiometabolic

Eric Rowinsky, MD

Clinical Development

Eric Rowinsky, MD

Clinical Development

Eric Rowinsky, MD

Clinical Development

Sasha Khursheed Said

Sales Strategy

Sasha Khursheed Said

Sales Strategy

Sasha Khursheed Said

Sales Strategy

Anne Horgan, PhD

Venture Capital

Anne Horgan, PhD

Venture Capital

Anne Horgan, PhD

Venture Capital

Ted B. Leggett, MS

Quality

Ted B. Leggett, MS

Quality

Ted B. Leggett, MS

Quality

Russell B. Allen

Commercialization

Russell B. Allen

Commercialization

Russell B. Allen

Commercialization

David Day

University Relations and Licensing

David Day

University Relations and Licensing

David Day

University Relations and Licensing

Our Services

Fully integrated R&D,

operated

end-to-end.

Radyus acts as an embedded R&D PMO, an extension of your operating team. Aligning, planning and executing across the full development lifecycle.
Development Strategy & Indication Selection

Portfolio-level strategy, target indication prioritization, value inflection planning

Development Strategy & Indication Selection

Portfolio-level strategy, target indication prioritization, value inflection planning

Regulatory Pathway & Agency Engagement

IND strategy, FDA interactions, briefing packages, regulatory positioning

Regulatory Pathway & Agency Engagement

IND strategy, FDA interactions, briefing packages, regulatory positioning

CMC & Manufacturing Strategy

Integrated CMC planning, CDMO strategy, phase-appropriate manufacturing readiness

CMC & Manufacturing Strategy

Integrated CMC planning, CDMO strategy, phase-appropriate manufacturing readiness

Nonclinical & Translational Planning

IND-enabling study design, translational strategy, data packages that withstand scrutiny

Nonclinical & Translational Planning

IND-enabling study design, translational strategy, data packages that withstand scrutiny

Clinical Development & Trial Operations

Protocol design, site strategy, CRO orchestration, execution oversight

Clinical Development & Trial Operations

Protocol design, site strategy, CRO orchestration, execution oversight

Program & Portfolio Management

End-to-end integration, timelines, budgets, risk management, governance

Program & Portfolio Management

End-to-end integration, timelines, budgets, risk management, governance

Diligence & Asset Readiness

Technical diligence, development gap analysis, execution plans for value creation

Diligence & Asset Readiness

Technical diligence, development gap analysis, execution plans for value creation

Commercial & Exit Strategy

Exit pathway design, pharma alignment, data positioning, transaction readiness for licensing or acquisition

Commercial & Exit Strategy

Exit pathway design, pharma alignment, data positioning, transaction readiness for licensing or acquisition

Ready to build your R&D roadmap?

Rely on

Radyus.

Ready to build your R&D roadmap?

Rely on

Radyus.

Ready to build your R&D roadmap?

Rely on

Radyus.